Aging Impairs Macrophage Phagocytosis Through Mitochondrial ROS-Induced Collagen Production

Area of Science:

• Immunology
• Cell Biology
• Aging Research

Background:

• Macrophages are crucial immune cells with phagocytic functions.
• The effects of aging on macrophage phagocytosis are not well understood.
• Phagocytosis is essential for immune defense and tissue homeostasis.

Purpose of the Study:

• To investigate the impact of aging on macrophage phagocytic activity.
• To elucidate the molecular mechanisms underlying age-related decline in phagocytosis.
• To identify potential therapeutic targets for enhancing immune function in aging.

Main Methods:

• In vitro and in vivo phagocytic assays using human and mouse macrophages.
• RNA-sequencing (RNA-seq) to analyze gene expression changes in aged macrophages.
• Protein interaction assays to study collagen-actin binding.
• Mitochondrial reactive oxygen species (ROS) measurement and manipulation.
• In vivo mouse models to assess therapeutic interventions.

Main Results:

• Aged macrophages exhibited significantly reduced phagocytic activity compared to young macrophages.
• Upregulated expression of extracellular matrix genes, particularly collagens (e.g., COL1A1), was observed in aged macrophages.
• Collagen was found to bind to actin filaments, inhibiting F-actin turnover and impairing phagocytosis.
• Mitochondrial ROS drives collagen overproduction in aged macrophages.
• MitoTEMPO treatment rejuvenated macrophage phagocytosis by restoring actin dynamics and enhancing bacterial clearance in vivo.

Conclusions:

• Aging impairs macrophage phagocytosis through collagen accumulation and disrupted actin dynamics.
• Mitochondrial ROS plays a key role in driving collagen overproduction and phagocytic dysfunction.
• MitoTEMPO shows potential as a therapeutic agent to restore macrophage function and promote healthy immune aging.